VERU Veru Inc.

Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility and novel chemotherapies for a variety of cancers.

$12.19  -0.96 (-7.30%)
As of 03/04/2021 15:59:13 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Consumer Staples
Drug Manufacturers—Specialty &
USA
USA
02/11/2013
71,911,903
8,543,946
$945,641,524
0.00%
SEC Edgar Online
10-Q
10-K
92536C103
US92536C1036
BDFBQ66

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
606.47
19.40
20.28
3.20%
3.34%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy